RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
When studied for the prevention of chemotherapy-induced cardiotoxicity, carvedilol improved some surrogate endpoints but not a change in EF. Worth it if therapy is only temporary? #cardioncology https://t.co/j1kPK8LKYq
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
From Abstract: “In this scenario, carvedilol had no impact on the incidence of early onset of LVEF reduction. However, the use of carvedilol resulted in a significant reduction in troponin levels and diastolic dysfunction.” https://t.co/url9FVO4NH
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
【HER2陰性乳癌200例ランダム化CECCY:アントラサイクリン系抗がん剤へのβ遮断薬併用は、6か月後の「10%以上EF低下」発生率はプラセボ群と同等。ただしTnIは有意に低値、拡張機能低下も抑制】 JACC https://t.co/nKaPvNwLS8
アントラサイクリン使用時における、βブロッカー(カルベジロール)の左室駆出率低下(<-10%)に対する予防効果を検討した研究。 6ヶ月時点では、プラセボ対照で有意差なし。 https://t.co/WAygXCoyMz
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
RT @JACCJournals: Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC http…
This makes sense like perioperative beta blockade makes sense. https://t.co/IZ7B8jF5wg
Prospective trial evaluates carvedilol for prevention of chemotherapy cardiotoxicity: https://t.co/woNhdhuSNl. #JACC https://t.co/FDs9t2i1xo
RT @JTLLERGO: CECCY Trial (β-blockers for prevention of cardiotoxicity): Carvedilol had no impact on the incidence of early onset of LVEF r…
RT @JTLLERGO: CECCY Trial (β-blockers for prevention of cardiotoxicity): Carvedilol had no impact on the incidence of early onset of LVEF r…
Do you CECCY? Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity https://t.co/uQnHqCjPzS
CECCY Trial (β-blockers for prevention of cardiotoxicity): Carvedilol had no impact on the incidence of early onset of LVEF reduction. However, the use of carvedilol resulted in a significant reduction in troponin levels and diastolic dysfunction. https:/
RT @troponinpapers: Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. https://t.co/kMMGyt0n8Z https://t.co/3Q2YaG7BWP
RT @troponinpapers: Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. https://t.co/kMMGyt0n8Z https://t.co/3Q2YaG7BWP
Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. https://t.co/kMMGyt0n8Z https://t.co/3Q2YaG7BWP
RT @crpisani: Congrats Monica! https://t.co/FPabNuUttg
【ACC】HER2陰性、EF正常の乳がん200例ランダム化:アントラサイクリン系薬開始によるEF低下を、β遮断薬は抑制せず。BNPにも有意差なし。ただしTnIは有意に低値、拡張障害も有意抑制。 JACC https://t.co/xEEpmqZQuz
Congrats Monica! https://t.co/FPabNuUttg